Conduit Pharmaceuticals Inc.
CDT
$0.6201
-$0.16-20.51%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -17.80M | -15.15M | -5.69M | -2.42M | -535.00K |
| Total Depreciation and Amortization | 457.00K | 5.00K | -- | -- | -- |
| Total Amortization of Deferred Charges | 929.00K | 143.00K | -- | -- | -- |
| Total Other Non-Cash Items | 6.85M | 4.72M | -1.30M | -3.67M | -4.67M |
| Change in Net Operating Assets | -117.00K | -387.00K | -2.21M | -2.03M | -2.52M |
| Cash from Operations | -9.68M | -10.67M | -9.20M | -8.11M | -7.72M |
| Capital Expenditure | -51.00K | -51.00K | -10.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.00K | 420.00K | 350.00K | 968.00K | 725.00K |
| Cash from Investing | -43.00K | 369.00K | 340.00K | 968.00K | 725.00K |
| Total Debt Issued | 3.23M | 1.25M | 55.00K | 66.00K | 2.29M |
| Total Debt Repaid | -776.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 3.50M | 114.00K | 264.00K | 151.00K | 151.00K |
| Repurchase of Common Stock | -- | -1.00K | -1.00K | -1.00K | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 113.00K | 80.00K | 8.49M | 8.49M | 8.49M |
| Cash from Financing | 6.07M | 1.44M | 8.81M | 8.71M | 10.93M |
| Foreign Exchange rate Adjustments | -16.00K | 287.00K | 265.00K | 271.00K | 299.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -1.00K |
| Net Change in Cash | -3.67M | -8.57M | 219.00K | 1.84M | 4.23M |